Pregnancy Outcome of Women with Antiphospholipid Syndrome, a Retrospective Descriptive Case StudyMoufalilou Aboubakar1, Roger Klikpezo2, Mèdessèvéronique Tognifode3, Justin Lewis Denakpo1, Faouzia Zouari4, Awadé Afoukou Achille Obossou3,5
- *Corresponding Author:
- Awadé Afoukou Achille Obossou
Obstetrician-Gynecologist, Assistant Professor, Faculty of Medicine
University-Assocated Hospital of the Departement of Borgou-Alibori (CHUD-BA)
E-mail: [email protected]
Received date: March 20, 2017; Accepted date: April 19, 2017; Published date: April 23, 2017
Citation: Aboubakar M, Klikpezo R, Tognifode M, Denakpo JL, Zouari F, et al. (2017) Pregnancy Outcome of Women with Antiphospholipid Syndrome, a Retrospective Descriptive Case Study. Gynecol Obstet (Sunnyvale) 7:435. doi:10.4172/2161-0932.1000435
Copyright: © 2017 Aboubakar M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
There is now a consensus on the need to provide healthcare, before and during pregnancy, to women at high risks of APS related obstetric complications diagnosed based on their medical (thrombosis) or obstetric (repeated embryo-fetal losses) history. However, the best therapeutic options are yet to be agreed upon. This study presents the experience of the Departement C of the Maternity and neonatology Center of Tunis (CMNT), a tertiary hospital in managing this pathology.
Patients and methodologies: This is a five-year descriptive retrospective study of cases reported to CMNT maternity department.
Outcome: 34 patients records were analyzed. The average age of the patients was 32 years with extremes of 21 and 44 years. The therapeutic option was a combination of acetyl salicylic acid and low molecular weight heparin. The success rate of the treatment was 97% full-term pregnancies against 12% without treatment.